Iradimed (IRMD) Scheduled to Post Quarterly Earnings on Thursday

Iradimed (NASDAQ:IRMD) is scheduled to be releasing its earnings data before the market opens on Thursday, October 31st. Analysts expect Iradimed to post earnings of $0.35 per share for the quarter. Iradimed has set its FY 2024 guidance at 1.520-1.620 EPS and its Q3 2024 guidance at 0.380-0.410 EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

Iradimed (NASDAQ:IRMD) last announced its earnings results on Thursday, August 1st. The medical equipment provider reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.05. The company had revenue of $17.93 million for the quarter, compared to analyst estimates of $17.70 million. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. During the same period in the prior year, the company posted $0.33 EPS. On average, analysts expect Iradimed to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Iradimed Stock Performance

Shares of NASDAQ IRMD opened at $52.55 on Wednesday. Iradimed has a fifty-two week low of $38.99 and a fifty-two week high of $52.94. The company has a market cap of $665.49 million, a PE ratio of 37.27 and a beta of 0.79. The business has a 50-day simple moving average of $48.51 and a two-hundred day simple moving average of $45.32.

Analyst Ratings Changes

Separately, Roth Mkm dropped their target price on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.